Adebrelimab + Chemotherapy as Neoadjuvant Therapy for Resectable NSCLC

NCT07035392 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

32

Enrollment

OTHER

Sponsor class

Conditions

Adebrelimab (SHR-1316)
NSCLC
Chemotherapy

Interventions

DRUG: Adebrelimab
DRUG: chemotherapy

Sponsor

Zhangzhou Municipal Hospital